Skip to main content

Advertisement

Log in

miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objectives

miR-200a has been established as a key regulator of HSC activation processes in liver fibrosis. Epigenetic silencing of miR-200a contributing to SIRT1 over-expression has been discussed in breast cancer; however, whether miR-200a controls SIRT1 gene expression in hepatic fibrosis is still unknown.

Methods and materials

We analyzed miR-200a regulation of SIRT1 expression in CCl4-induced liver fibrosis and TGF-β1-mediated activation of HSC. miR-200a, SIRT1, α-SMA, Col1A1, Notch1 and NICD expression were estimated by Western blotting, qRT-PCR and Immunohistochemistry. HSCs were transfected with miR-200a mimic, miR-200a inhibitor and SIRT1-RNAi. Luciferase reporter assays further confirmed the interaction between miR-200a and the SIRT1 mRNA 3'-UTR. Cell proliferation ability was assessed by MTT and cell cycle.

Results

We found that treatment activated HSC with miR-200a mimics, restored miR-200a expression and reduced SIRT1 levels. Conversely, treatment activated HSC with miR-200a inhibitors, decreased miR-200a expression and up-regulated SIRT1 levels. Restoration of miR-200a or the knockdown of SIRT1 prevented HSC activation and proliferation. We have established the SIRT1 transcript as subject to regulation by miR-200a, through miR-200a targeting of SIRT1 3’-UTR. Finally, HSC transfected with SIRT1-siRNA increased the levels of Notch1 protein and mRNA expression.

Conclusions

Our study demonstrated that miR-200a regulates SIRT1/Notch1 expression during HSC activation and fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

HSC:

Hepatic stellate cell

ECM:

Extracellular matrix

α-SMA:

α-Smooth muscle actin

TGF-β1:

Transforming growth factor-β1

SIRT1:

Silent information regulator 1

TIMP-1:

Tissue inhibitor of metalloproteinase-1

miR:

MicroRNA

3′-UTR:

3′-Untranslated region

NICD:

Notch1-intercellular domain

References

  1. Mimche PN, Brady LM, Bray CF, Mimche SM, Thapa M, King TP, et al. The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice. Hepatology. 2015;62:900–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Meng Y, Liang Y, Liu M. The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis. PLoS One. 2015;10:e0120110.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64:830–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ganji SH, Kashyap ML, Kamanna VS. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease. Metabolism. 2015;64(9):982–90.

    Article  CAS  PubMed  Google Scholar 

  5. Wu LY, Liu S, Liu Y, Guo C, Li H, Li W, et al. Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C. Clin Immunol 2015;158(1):77–87.

    Article  CAS  PubMed  Google Scholar 

  6. Hu J, Chen C, Liu Q, Liu B, Song C, Zhu S, et al. The role of miR-31/FIH1 pathway in TGFbeta-induced liver fibrosis. Clin Sci (Lond). 2015;129:305–17.

    Article  CAS  Google Scholar 

  7. Lin X, Chen Y, Lv S, Tan S, Zhang S, Huang R, et al. Gypsophila elegans isoorientin attenuates CCl-induced hepatic fibrosis in rats via modulation of NF-kappaB and TGF-beta1/Smad signaling pathways. Int Immunopharmacol. 2015;28:305–12.

    Article  CAS  PubMed  Google Scholar 

  8. Ramezani-Moghadam M, Wang J, Ho V, Iseli TJ, Alzahrani B, Xu A, et al. Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion. J Biol Chem. 2015;290:5533–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Pannem RR, Dorn C, Hellerbrand C, Massoumi R. Cylindromatosis gene CYLD regulates hepatocyte growth factor expression in hepatic stellate cells through interaction with histone deacetylase 7. Hepatology. 2014;60:1066–81.

    Article  CAS  PubMed  Google Scholar 

  10. Stein C, Riedl S, Ruthnick D, Notzold RR, Bauer UM. The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes. Nucleic Acids Res. 2012;40:9522–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Simic P, Williams EO, Bell EL, Gong JJ, Bonkowski M, Guarente L. SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis. Cell Rep. 2013;3:1175–86.

    Article  CAS  PubMed  Google Scholar 

  12. Yuan H, Su L, Chen WY. The emerging and diverse roles of sirtuins in cancer: a clinical perspective. Oncotargets Ther. 2013;6:1399–416.

    CAS  Google Scholar 

  13. Jiang JX, Chen X, Fukada H, Serizawa N, Devaraj S, Torok NJ. Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-alpha-converting enzyme activity in mice. Hepatology. 2013;58:1339–48.

    Article  CAS  PubMed  Google Scholar 

  14. Mallick S, D’Mello SR. JAZ (Znf346), a SIRT1-interacting protein, protects neurons by stimulating p21 (WAF/CIP1) protein expression. J Biol Chem. 2014;289:35409–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Murayama A, Ohmori K, Fujimura A, Minami H, Yasuzawa-Tanaka K, Kuroda T, et al. Epigenetic control of rDNA loci in response to intracellular energy status. Cell. 2008;133:627–39.

    Article  CAS  PubMed  Google Scholar 

  16. Xie M, Liu M, He CS. SIRT1 regulates endothelial Notch signaling in lung cancer. PLoS One. 2012;7:e45331.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Boareto M, Jolly MK, Lu M, Onuchic JN, Clementi C, Ben-Jacob E. Jagged-delta asymmetry in Notch signaling can give rise to a sender/receiver hybrid phenotype. Proc Natl Acad Sci USA. 2015;112:E402–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Dey N, Bera A, Das F, Ghosh-Choudhury N, Kasinath BS, Choudhury GG. High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression. Cell Signal. 2015;27:1276–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Hu W, Li M, Hu R, Li T, Meng X. microRNA-18b modulates insulin-like growth factor-1 expression in deer antler cell proliferation by directly targeting its 3′ untranslated region. DNA Cell Biol. 2015;34:282–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Sun X, He Y, Ma TT, Huang C, Zhang L, Li J. Participation of miR-200a in TGF-beta1-mediated hepatic stellate cell activation. Mol Cell Biochem. 2014;388:11–23.

    Article  CAS  PubMed  Google Scholar 

  21. Xiao Y, Wang J, Chen Y, Zhou K, Wen J, Wang Y, et al. Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling. Cell Signal. 2014;26:925–32.

    Article  CAS  PubMed  Google Scholar 

  22. Liu Y, Liu Q, Ye G, Khan A, Liu J, Gan F, et al. Protective effects of selenium-enriched probiotics on carbon tetrachloride-induced liver fibrosis in rats. J Agric Food Chem. 2014;63(1):242–9.

    Article  Google Scholar 

  23. Fujiyoshi M, Kuno A, Gotoh M, Fukai M, Yokoo H, Kamachi H, et al. Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma. J Gastroenterol. 2015;50(11):1134–44.

    Article  CAS  PubMed  Google Scholar 

  24. Yang JJ, Tao H, Li J. Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives. Expert Opin Ther Targets. 2014;18:1011–21.

    Article  CAS  PubMed  Google Scholar 

  25. Shah N, Nelson JE, Kowdley KV. MicroRNAs in liver disease: bench to bedside. J Clin Exp Hepatol. 2013;3:231–42.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Li L, Sun Q, Li Y, Yang Y, Chang T, Man M, et al. Overexpression of SIRT1 induced by resveratrol and inhibitor of miR-204 suppresses activation and proliferation of microglia. J Mol Neurosci. 2015;56:858–67.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was funded by Anhui Provincial Natural Science Foundation (1608085MH200) and National Natural Science Foundation of China (81600477) and Anhui Medical University Foundation (2015xjk014).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun Li.

Ethics declarations

Conflict of interest

There are none.

Ethical approval

All applicable international, national, and institutional guidelines for the care and use of animals were followed.

Additional information

Responsible Editor: Liwu Li.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, JJ., Tao, H., Liu, LP. et al. miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway. Inflamm. Res. 66, 341–352 (2017). https://doi.org/10.1007/s00011-016-1020-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-016-1020-4

Keywords

Navigation